Price$1.06-0.03 (-2.29%)
01:30 PM07:15 PM
News · 26 weeks33-25%
2025-12-072026-05-31
Mix1390d
- SEC Filings6(46%)
- Leadership3(23%)
- Other2(15%)
- Earnings2(15%)
Latest news
25 items- PREurope's Cannabis Boom Is Accelerating as Billions Flow into Licensed MarketsNEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Europe's licensed cannabis industry is starting to look like one of the most exciting growth stories in the global cannabis market. What was once a fragmented, slow-moving sector is now gaining serious momentum as more countries open up medical cannabis programs, expand patient access, and create clearer licensing frameworks for producers and distributors. Germany continues to lead the charge after its cannabis reforms, but countries like the UK, Portugal, Italy, France, Switzerland, and the Czech Republic are also becoming major pieces of the puzzle. Investors and operators are paying close attention because
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Reports Second Quarter Fiscal 2026 ResultsOrganigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the second quarter ended March 31, 2026 ("Q2 Fiscal 2026" or "Q2"). Q2 FISCAL 2026 HIGHLIGHTS Gross Revenue: $93.3 million (-9% year-over-year). Net Revenue: $59.8 million (-9% year-over-year). International Revenue: $6.1 million (0% year-over-year). Adjusted EBITDA2: $0.9 million (-82% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2 in flower, #2 in pre-rolls, #3 in edibles, and #5 in beverages1. Sanity Group GmbH ("Sanity Group") Acquisition: Subsequent
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2026 ended March 31, 2026, on Tuesday, May 12, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, May 12, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/574618022?pwd=FVnom6fM To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After regist
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit FacilitiesOrganigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously announced acquisition (the "Acquisition") of Sanity Group, pursuant to the terms of a share purchase agreement dated February 18, 2026 (the "Share Purchase Agreement"). In connection with closing of the Acquisition, a wholly owned subsidiary of the Company acquired all of the issued and outstanding shares of Sanity Group not already owned by the Company for an upfront purchase price paid on closing of €107.3 million, consisting of €78.0 million in cash and €29.3 million in share consideration (th
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special MeetingOrganigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the "Transaction") of Sanity Group GmbH ("Sanity Group") and the related private placement financing (the "Private Placement") with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco ("BAT") at the Company's annual general and special meeting of shareholders (the "Shareholders") held on March 30, 2026 (the "Meeting"). Shareholders approved an ordinary resolution (the "Transaction Resolution") authorizing (i)
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbHISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Recommending Shareholders Vote FOR the Transaction Resolution Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annual General and Special Meeting of Shareholders (the "Mee
- PROrganigram Announces Mailing of Management Information Circular in Connection with Annual General and Special MeetingSpecial Meeting to Approve Acquisition of Sanity Group GmbH Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the "Circular") and related materials (the "Meeting Materials") for its annual and special meeting (the "Meeting") of the holders of its common shares (the "Shareholders") to be held on March 30, 2026. The Circular is available under Organigram's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. In addition to routine annual business to be conducted, Shareholders at the Meeting will be asked to consider and vote u
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand EquityFAST™-powered SHRED Shotz extends the SHRED brand into shot-sized beverages Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1 is pleased to announce the launch of SHRED Shotz, a compact, single-serve 65ml cannabis beverage powered by FAST™, Organigram's fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305717369/en/ This launch reflects Organigram's focus on differentiated innovation while leveraging the scale of SHRED, one of the Company's best-known brands. SHRED sur
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in AustraliaLaunch aligns with rising Australian demand for alternatives to flower and strengthens Organigram's global medical cannabis presence Organigram Global Inc. ("Organigram" or the "Company") today announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cannabis vape and pastille products in Australia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224218487/en/ Australia has become one of the world's most dynamic medical cannabis markets, with increasing approvals for access and prescribers utilising a broader range of dosage forms1. While flower remains a core category, alt
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity GroupOrganigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading global cannabis company, today announced that it has entered into a subscription agreement (the "Subscription Agreement") with BT DE Investments Inc. ( "BAT"), a wholly-owned subsidiary of British American Tobacco p.l.c. (NYSE:BTI), in connection with its previously announced proposed acquisition (the "Acquisition") of Sanity Group GmbH ("Sanity" or "Sanity Group"), including shares of Sanity ow
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis CompanyAccretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company with Leadership Positions in the World's Two Largest Federally Legal Cannabis Markets Organigram to acquire Sanity Group for up-front consideration of €113.4 million plus a maximum earnout of up to €113.8 million tied to financial performance. Proposed Acquisition of the Berlin‑based company unites two leaders in the largest federally legal cannabis markets, boosting commercial opportunities, strengthening access to best‑in‑class leadership, and expanding a valuable network of supply-chain partners. Sanity is achieving top-line growth. Annual net revenue increased from €9 million in
- SECSEC Form 6-K filed by Organigram Global Inc.6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)
- PROrganigram Reports First Quarter Fiscal 2026 ResultsStrong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2
OGI FAQ
6 questionsWhat does Organigram Global Inc. do?
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis...Where does OGI stock trade?
Organigram Global Inc. (OGI) is listed on NASDAQ.What sector and industry is OGI in?
Organigram Global Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about OGI?
Organigram Global Inc. has had 7 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2026-01-27. Recent price targets range from $530.00 to $570.00.What companies are similar to OGI?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare OGI side-by-side with any of them on Quantisnow.How can I track OGI on Quantisnow?
Quantisnow aggregates Organigram Global Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OGI to receive live email and push alerts on every new disclosure.